Christian Angermayer

Christian Angermayer is an entrepreneur and investor and the founder of Apeiron Investment Group, his private investment firm, and Presight Capital, the flagship venture capital fund for Apeiron. Collectively, Christian has experienced investing and managing companies in the Financial Services (especially fintech and crypto assets), Technology, Life Sciences, Media & Entertainment and Real Estate & Prop-Tech sectors. In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with stock market listed US SPAC Alnylam in 2003 and has a $13bn market cap today.